19-Jun-2021 Contemporary ADT in elderly patients with advanced prostate cancer

Medihub

19-Jun-2021 Contemporary ADT in elderly patients with advanced prostate cancer

Speakers: Dr. Tan Teck Wei (Tan Tock Seng Hospital, Singapore); Prof. Ravidran Kanesvaran (National Cancer Centre Singapore); Prof. Melvin Chua (National Cancer Centre Singapore

In this Ferring sponsored session, distinguished panelists will share their rich clinical experiences on ADT for elderly prostate cancer patients, walk the audience through Geriatric Oncology principles/consensus (from SIOU), ADT (agonist vs. antagonist, patient benefits), toxicity profiling, and paint out a list of issues of ADT in elderly PCa vis-à-vis risk profiles, and move to ADT/combinatorial therapy (with C/T, novel AA) for which subgroups of patients, esp. metastatic PCa (HSPC, CRPC), followed by challenges in managing these cases. An interactive live Q and A session will ensue.

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK